Chicago IL 心脏病临床试验
9项针对 心脏病的研究正在 Chicago及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
ELEVATE-HFpEF Clinical Study
招募中
- The University of Chicago Medical Center, Chicago
Transition to KPL-387 Monotherapy Dosing & Administration Study
招募中2 期
- Investigational Site 013, Chicago
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
招募中
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
招募中
- Advocate Christ Medical Center, Chicago
- Northwestern University, Chicago
- University of Chicago, Chicago
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
招募中3 期
- John H. Stroger, Jr. Hospital of Cook County, Chicago
- University of Chicago - Medical Center, Chicago
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
招募中
- University of Chicago, Chicago
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
招募中
- University of Chicago, Chicago
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
招募中观察性研究欢迎健康志愿者
- University of Chicago Medical Center, Chicago
PARTNER 3 Trial - Aortic Valve-in-Valve
招募中
- Northwestern University Hospital, Chicago
- Rush University Medical Center, Chicago
其他城市的 心脏病试验
- New York City, NY18 项研究
- Boston, MA14 项研究
- Cleveland, OH13 项研究
- Los Angeles, CA12 项研究
- Portland, OR11 项研究
- Philadelphia, PA11 项研究
- Atlanta, GA10 项研究
- Rochester, MN10 项研究
- Dallas, TX10 项研究
- Durham, NC10 项研究
- Washington, DC9 项研究
- Baltimore, MD9 项研究
Chicago的其他研究
- 非小细胞肺癌61 项研究
- 乳腺癌58 项研究
- 癌症(所有类型)51 项研究
- 转移性癌症45 项研究
- 前列腺癌45 项研究
- 肥胖症41 项研究
- 肺癌41 项研究
- 卵巢癌36 项研究
- 卒中34 项研究
- 结直肠癌33 项研究
- 心力衰竭31 项研究
- 超重28 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月5日。每项研究自行设定入选标准,由研究团队决定谁能参与。